← Open Payments lookup

MEAGAN BOWCOCK: Open Payments

NPI 1629854955 · MARION, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,276 in 54 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $416 · 2025 $1,276

Food & beverage: $1,276
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.20$312
E.R. Squibb & Sons, L.L.C.3$269
ABBVIE INC.13$210
Alkermes, Inc.9$155
Supernus Pharmaceuticals, Inc.2$150
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$86
Corium, LLC1$29
Vanda Pharmaceuticals Inc.1$26
Neurocrine BioSciences, Inc.1$20
Sage Therapeutics, LLC1$19

Products named: REXULTI, COBENFY, VRAYLAR, Qelbree, ARISTADA, CAPLYTA, VIVITROL, ABILIFY ASIMTUFII.

Industry payments across MA — which companies pay providers there.